title: Risk Evaluation and Mitigation Strategy (REMS): FDA Perspective on What Physicians Need to Know.
authors.affiliation: U.S. Food and Drug Administration, Silver Spring, MD, USA.
authors.forename: Gary H
authors.initials: GH
authors.lastname: Slatko
mesh_terms: D006801:Humans; D054539:Medication Therapy Management; D010819:Physician's Role; D011358:Product Surveillance, Postmarketing / Q000379:methods*; D018570:Risk Assessment / Q000379:methods*; D014481:United States; D014486:United States Food and Drug Administration